Clinical and Experimental Pharmacology and Physiology · 2022 · 10 citations · 39 references
MedicineNeurosciencePharmacologyCell JunctionsInflammationSepsisBlood-brain Barrier BiologyBlood-brain Barrier DysfunctionBlood-brain Barrier PharmacologyNeuroprotectionSepsis PathophysiologyVascular PermeabilityBlood - Brain Barrier FunctionBlood-brain Barrier PathologyBlood-brain Barrier PermeabilityBlood-tissue Barrier PermeabilitySepsis-associated Barrier DysfunctionSepsis-associated EncephalopathyTight Junction Biology
Blood-brain barrier (BBB) injury is involved in the pathogenesis of sepsis-associated encephalopathy. In this study, we used dihydroartemisinin (DHA), a derivative of artemisinin, to treat a cecal ligation and puncture (CLP)-induced mouse sepsis model and a tumour necrosis factor α (TNF-α)-stimulated human cerebral microvessel endothelial cells (hCMEC)/D3 cell line. We found that DHA decreased BBB permeability and increased the expression of the tight junction protein occludin (OCLN) in the CLP model. In hCMEC/D3 cells, DHA decreased TNF-α-induced hyperpermeability and increased the expression of OCLN. DHA also repressed SNAI1 expression in the CLP mouse model and in TNF-α-stimulated hCMEC/D3 cells. These data suggest that DHA protects BBB permeability during sepsis by stimulating the expression of OCLN, by downregulating the expression of the SNAI1 transcription factor.
39
Immunodesign of experimental sepsis by cecal ligation and puncture
Daniel Rittirsch, Markus Huber‐Lang, Michael A. Flierl et al. · Nature Protocols · 2008 · 2.2K citations · Full text